These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 17553671

  • 1. Sodium valproate versus lamotrigine: a randomised comparison of efficacy, tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy.
    Stephen LJ, Sills GJ, Leach JP, Butler E, Parker P, Hitiris N, Leach VM, Wilson EA, Brodie MJ.
    Epilepsy Res; 2007 Jul; 75(2-3):122-9. PubMed ID: 17553671
    [Abstract] [Full Text] [Related]

  • 2. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
    Coppola G, Auricchio G, Federico R, Carotenuto M, Pascotto A.
    Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
    [Abstract] [Full Text] [Related]

  • 3. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K, Wang X, Xi Z, Yan Y.
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [Abstract] [Full Text] [Related]

  • 4. Serum androgen levels and testicular structure during pubertal maturation in male subjects with epilepsy.
    Mikkonen K, Tapanainen P, Pakarinen AJ, Päivänsalo M, Isojärvi JI, Vainionpää LK.
    Epilepsia; 2004 Jul; 45(7):769-76. PubMed ID: 15230700
    [Abstract] [Full Text] [Related]

  • 5. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
    Baumann RJ, Fakhoury TA, Kustra RP, Vuong A, Hammer AE, Messenheimer JA.
    Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
    [Abstract] [Full Text] [Related]

  • 6. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.
    Stephen LJ, Kwan P, Shapiro D, Dominiczak M, Brodie MJ.
    Epilepsia; 2001 Aug; 42(8):1002-6. PubMed ID: 11554885
    [Abstract] [Full Text] [Related]

  • 7. Evaluate the effects of antiepileptic drugs on reproductive endocrine system in newly diagnosed female epileptic patients receiving either Valproate or Lamotrigine monotherapy: A prospective study.
    Sidhu HS, Srinivasa R, Sadhotra A.
    Epilepsy Res; 2018 Jan; 139():20-27. PubMed ID: 29144993
    [Abstract] [Full Text] [Related]

  • 8. Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Hwang H, Kim H, Kim SH, Kim SH, Lim BC, Chae JH, Choi JE, Kim KJ, Hwang YS.
    Brain Dev; 2012 May; 34(5):344-8. PubMed ID: 21893390
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological outcomes in newly diagnosed epilepsy.
    Mohanraj R, Brodie MJ.
    Epilepsy Behav; 2005 May; 6(3):382-7. PubMed ID: 15820347
    [Abstract] [Full Text] [Related]

  • 10. Long-term efficacy of valproate versus lamotrigine in treatment of idiopathic generalized epilepsies in children and adolescents.
    Mazurkiewicz-Bełdzińska M, Szmuda M, Matheisel A.
    Seizure; 2010 Apr; 19(3):195-7. PubMed ID: 20167512
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
    Chowdhury A, Brodie MJ.
    Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
    [Abstract] [Full Text] [Related]

  • 12. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults.
    Steinhoff BJ, Ueberall MA, Siemes H, Kurlemann G, Schmitz B, Bergmann L, LAM-SAFE Study Group.
    Seizure; 2005 Dec; 14(8):597-605. PubMed ID: 16278088
    [Abstract] [Full Text] [Related]

  • 13. Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: A prospective study.
    Sidhu HS, Srinivas R, Sadhotra A.
    Seizure; 2017 May; 48():15-21. PubMed ID: 28365440
    [Abstract] [Full Text] [Related]

  • 14. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ, Rahey SR, Sadler RM.
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [Abstract] [Full Text] [Related]

  • 15. Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy.
    Kim JY, Lee HW.
    Epilepsia; 2007 Jul; 48(7):1366-70. PubMed ID: 17565596
    [Abstract] [Full Text] [Related]

  • 16. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
    Evans BK, Kustra RP, Hammer AE.
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
    Lee BI, No SK, Yi SD, Lee HW, Kim OJ, Kim SH, Kim MK, Kim SE, Kim YS, Kim JM, Lee SJ, Shin DJ, Park SP, Kim YI, Heo K, Cho YW, Cho YJ, Kim YN.
    Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
    [Abstract] [Full Text] [Related]

  • 19. Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group.
    Brodie MJ, Yuen AW.
    Epilepsy Res; 1997 Mar; 26(3):423-32. PubMed ID: 9127723
    [Abstract] [Full Text] [Related]

  • 20. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
    Sale ME, Natarajan S, Biton V, Vuong A, Hammer AE, Messenheimer JA, Blum D.
    Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.